Active search of adult patients with persistently low serum alkaline phosphatase levels for the diagnosis of hypophosphatasia

Active search of adult patients with persistently low serum alkaline phosphatase levels for the diagnosis of hypophosphatasia

Archives of Endocrinology and Metabolism, April 2021

33844893

Lucio Henrique Rocha Vieira, Kleison Cordeiro Peixoto, Caroline Leal Flósi, Maria Lucia Fleiuss de Farias, Miguel Madeira

Alkaline phosphatase (ALP) is the main laboratory marker of hypophosphatasia (HPP), a rare disease unknown to most physicians. The prevalence of HPP has been widely discussed in the literature due to the diverse phenotypes of HPP. The purpose of this study was to search for patients with hypophosphatasemia based on previous biochemistry tests and reevaluate them to confirm the diagnosis of HPP. A total of 289,247 biochemical tests for ALP in adults were performed from 2015 to 2019 in two tertiary hospitals in Rio de Janeiro were reviewed (Clementino Fraga Filho University Hospital - HUCFF - and Bonsucesso Federal Hospital - BFH). A total of 1,049 patients were identified with ALP levels below 40 U/L, and 410 patients had hypophosphatasemia confirmed by at least two exams. After the active search of medical reports and/or interviews based on structured questionnaires, 398 subjects were excluded due to secondary causes of reduced ALP. The remaining 12 patients were invited to attend the medical consultation at HUCFF, accompanied by at least one first-degree relative. None of the patients or their relatives had a history or clinical manifestations consistent with HPP. Serum ALP was within reference values in all relatives, but persistently low in further laboratory evaluation in all the 12 patients, in whom secondary causes were ruled out. Thus, we cannot exclude the possibility that they might carry the mutations associated with HPP. Further image evaluations and genetic testing would be appropriate to confirm this asymptomatic adult form of HPP.